Bellin, Gloria
 Distribuzione geografica
Continente #
NA - Nord America 379
EU - Europa 355
AS - Asia 264
SA - Sud America 22
AF - Africa 2
OC - Oceania 1
Totale 1.023
Nazione #
US - Stati Uniti d'America 376
GB - Regno Unito 125
CN - Cina 102
SG - Singapore 99
IT - Italia 42
SE - Svezia 34
DE - Germania 31
FR - Francia 30
IE - Irlanda 28
RU - Federazione Russa 28
HK - Hong Kong 24
BR - Brasile 20
FI - Finlandia 17
VN - Vietnam 17
UA - Ucraina 7
AT - Austria 5
IL - Israele 5
BE - Belgio 4
ID - Indonesia 4
IN - India 3
AE - Emirati Arabi Uniti 2
CA - Canada 2
MY - Malesia 2
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
JP - Giappone 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
TR - Turchia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 1.023
Città #
Southend 111
Chandler 82
Singapore 41
Woodbridge 39
Dallas 29
Dublin 28
Jacksonville 27
Beijing 24
Hong Kong 24
Ashburn 16
Lawrence 11
Princeton 11
Wilmington 11
Council Bluffs 8
New York 8
Helsinki 7
Dong Ket 6
Shenyang 6
Ann Arbor 5
Columbus 5
Jiaxing 5
Nanjing 5
Verona 5
Vienna 5
Brussels 4
Cagliari 4
Hebei 4
Houston 4
Jakarta 4
Los Angeles 4
Munich 4
Padova 4
Shanghai 4
The Dalles 4
Venice 4
Frankfurt am Main 3
Guangzhou 3
Hangzhou 3
Jinan 3
Kent 3
London 3
Nottingham 3
San Francisco 3
Taizhou 3
Cambridge 2
Catanzaro 2
Foggia 2
Haikou 2
Lancaster 2
Lanzhou 2
Nanchang 2
Ningbo 2
Nuremberg 2
Parma 2
Redmond 2
Seattle 2
Taiyuan 2
Tel Aviv 2
Tianjin 2
Wuhan 2
Auburn Hills 1
Berlin 1
Bishkek 1
Boardman 1
Boston 1
Brooklyn 1
Caatiba 1
Cabo Frio 1
Cairo 1
Campinas 1
Canberra 1
Caracas 1
Carney 1
Casablanca 1
Chennai 1
Chicago 1
Colombo 1
Conselheiro Lafaiete 1
Córdoba 1
Düsseldorf 1
Fairfield 1
Goiânia 1
Guarulhos 1
Hengyang 1
Heshan 1
Ho Chi Minh City 1
Irecê 1
Jaraguá 1
Juazeiro 1
Juazeiro do Norte 1
Jundiaí 1
Kochi 1
Krasnodar 1
Lençóis Paulista 1
Manassas 1
Mexico City 1
Miami 1
Milan 1
Montalvânia 1
Montreal 1
Totale 662
Nome #
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 117
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 117
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 106
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 104
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 98
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 96
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 95
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 93
Heparanase regulates M1 macrophage polarization and the crosstalk between macrophages and tubular epithelial cells after kidney ischemia/reperfusion injury. 85
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 75
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 72
Totale 1.058
Categoria #
all - tutte 4.047
article - articoli 3.735
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 312
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 2 8 8 7 2 0 0 0 7 16
2021/202270 2 13 0 17 0 0 3 6 4 3 0 22
2022/2023198 12 28 16 39 18 41 4 7 24 0 6 3
2023/202492 5 14 9 3 12 11 0 9 1 4 21 3
2024/2025222 13 17 7 35 11 10 10 10 44 6 18 41
2025/202680 49 28 3 0 0 0 0 0 0 0 0 0
Totale 1.058